Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma
- PMID: 26846106
- DOI: 10.1007/s13277-016-4931-3
Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma
Abstract
Sonodynamic therapy (SDT) has shown great potential as an approach for cancer treatment, and hyperthermotherapy (HT) is also a promising cancer therapy. Here, we investigate whether HT could improve the efficacy of SDT and to make a preliminary exploration on potential mechanism. Xenograft tumor was established in nude mice model, and SNB19 and U87MG glioma cell lines were utilized for in vitro experiment. Alamar blue assay was performed to assess cell viability. Optical microscope was used to characterize the morphology changes of the glioma cells induced by SDT and HT treatments. Apoptotic rate, mitochondrial membrane potential (MMP), and intracellular production of reactive oxygen species (ROS) were examined by flow cytometer. The cell apoptosis of tumor tissues were detected by TUNEL assay. Furthermore, the expression of apoptosis-related proteins was detected with Western blot in vitro and immunohistochemistry in vivo. SDT plus HT group could significantly reduce the cell viability with circular-cell morphological change, compared with SDT group, and cell viability was decreased depending on raise of 5-ALA concentration, ultrasound exposure time, and temperature. The results also indicate that HT increased a conspicuous apoptosis, ROS production, and a remarkable loss in MMP induced by 5-ALA-SDT in vitro. Meanwhile, our data also demonstrated that the combined treatment could significantly induce apoptosis and delay tumor growth in vivo. Furthermore, in both in vitro and in vivo experiments, SDT plus HT group expressed significantly higher protein levels of Bax and cleaved caspase-3, 8, and 9 compared to SDT, HT, and control groups and significantly lower protein level of bcl-2 than the other three groups, while the expression of these proteins was unchanged between HT and control groups. HT may provide an important promotion on 5-ALA-SDT and further propose that SDT in combination with HT is a new potential application for the treatment of human glioma.
Keywords: 5-aminolevulinic acid; Antitumor effect; Apoptosis; Glioma; Hyperthermotherapy; Sonodynamic therapy.
Similar articles
-
5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice.PLoS One. 2015 Jul 10;10(7):e0132074. doi: 10.1371/journal.pone.0132074. eCollection 2015. PLoS One. 2015. PMID: 26161801 Free PMC article.
-
Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.J Neurosurg. 2018 Dec 1;129(6):1416-1428. doi: 10.3171/2017.6.JNS162398. Epub 2018 Jan 19. J Neurosurg. 2018. PMID: 29350596
-
5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization.Cell Physiol Biochem. 2018;47(1):83-96. doi: 10.1159/000489751. Epub 2018 May 9. Cell Physiol Biochem. 2018. PMID: 29763901
-
Sonodynamic Therapy and Sonosensitizers for Glioma Treatment: A Systematic Qualitative Review.World Neurosurg. 2023 Oct;178:60-68. doi: 10.1016/j.wneu.2023.07.030. Epub 2023 Jul 15. World Neurosurg. 2023. PMID: 37454909
-
Mechanistic insights and basis for real-time monitoring and closed-loop feedback control in sonodynamic therapy for glioblastoma.Biomed Pharmacother. 2025 Sep;190:118433. doi: 10.1016/j.biopha.2025.118433. Epub 2025 Aug 8. Biomed Pharmacother. 2025. PMID: 40782435 Review.
Cited by
-
Curcumin-Triterpene Type Hybrid as Effective Sonosensitizers for Sonodynamic Therapy in Oral Squamous Cell Carcinoma.Pharmaceutics. 2023 Jul 23;15(7):2008. doi: 10.3390/pharmaceutics15072008. Pharmaceutics. 2023. PMID: 37514194 Free PMC article.
-
Sonodynamic Therapy for the Treatment of Intracranial Gliomas.J Clin Med. 2021 Mar 6;10(5):1101. doi: 10.3390/jcm10051101. J Clin Med. 2021. PMID: 33800821 Free PMC article. Review.
-
Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.Cells. 2019 Nov 13;8(11):1428. doi: 10.3390/cells8111428. Cells. 2019. PMID: 31766152 Free PMC article. Review.
-
β3GNT9 as a prognostic biomarker in glioblastoma and its association with glioblastoma immune infiltration, migration and invasion.Front Oncol. 2023 Sep 12;13:1214413. doi: 10.3389/fonc.2023.1214413. eCollection 2023. Front Oncol. 2023. PMID: 37771444 Free PMC article.
-
Emerging Applications of Ultrasound-Contrast Agents in Radiation Therapy.Ultrasound Med Biol. 2021 Jun;47(6):1465-1474. doi: 10.1016/j.ultrasmedbio.2021.01.032. Epub 2021 Feb 27. Ultrasound Med Biol. 2021. PMID: 33653626 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials